Eli Lilly Shares Rise 4.36% as METiS Deal Sets $1.1 Billion in Milestones
Eli Lilly traded at $1,294.36, up from $1,240.34, on October 20. The METiS collaboration includes $1.1 billion in milestones; the upfront payment is reported in the low double-digit millions of dollars.